α4α7 peptide monomer and dimer antagonists
Abstract:
The invention relates to peptide dimer compounds and peptide monomer compounds that potently inhibit binding of α4β7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, possess high selectivity against α4β1 binding, and have high stability under gastrointestinal conditions.
Public/Granted literature
Information query
Patent Agency Ranking
0/0